Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. sophomore Avg
|
New words:
Accusorb, afflict, antagonist, anti, Arab, Arabia, began, behavioral, big, Bio, bowel, Cantor, Centaur, China, CNS, Comfort, comfortable, Concentration, conclusion, conference, constrained, contact, convince, count, CRB, deteriorate, diarrhea, dispersed, doubling, Egypt, Elan, electronically, endorse, Ernest, erosive, fatal, Fitzgerald, fixed, float, forecasted, forfeited, Foundation, fourth, furnish, furnished, glandular, hematocrit, Henry, histamine, IBD, inbound, induced, inflammation, inhibitor, Inside, intermittent, itching, Kingdom, leadership, Liechtenstein, LOQ, Mario, meaningful, mediated, Midwest, Morocco, network, Oppenheimer, orexigenic, overhead, Pall, past, Patterson, peak, pertain, pertaining, pinna, point, poor, potent, profile, Project, QoL, Raymond, receptor, red, renovating, renovation, resell, Riley, ROU, route, RSU, Saudi, Schein, secondary, SkyePharma, solution, sponsorship, Stifel, stomach, sublease, surprisingly, territory, thirty, Townsend, transmission, Treadway, uncover, underlying, uniformly, unintended, unqualified, VCA, version, visit, Vitality, vomiting, warehouse, Wellbeing, witnessed
Removed:
alter, biosimilar, carprofen, classification, Eli, entry, erythropoeitin, exact, expressing, Ideally, irrevocably, Lilly, minimize, newly, nonbinding, optimized, palatability, participate, patented, protected, realization, relief, relying, reticulocyte, retrospective, revaluation, royalty, settled, signal, Stephen, streamline, Subtopic, Sundlof, survive, telephone, upfront
Filing tables
Filing exhibits
Related press release
Associated KIN transcripts
KIN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement Nos. 333-193039, 333-200687, 333-211839 and 333-226321 on Form S-8 and Registration Statement No. 333-222597 on Form S-3 of our reports dated March 6, 2019, relating to the consolidated financial statements of Kindred Biosciences, Inc. and Subsidiary (the “Company”) and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Kindred Biosciences, Inc. for the year ended December 31, 2018.
/s/ KMJ Corbin & Company LLP
Costa Mesa, California
March 6, 2019